mesalamine has been researched along with Lymphocytosis in 2 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Lymphocytosis: Excess of normal lymphocytes in the blood or in any effusion.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fernández-Bañares, F | 1 |
Salas, A | 1 |
Esteve, M | 1 |
Espinós, J | 1 |
Forné, M | 1 |
Viver, JM | 1 |
Kondo, H | 1 |
Watanabe, J | 1 |
Iwasaki, H | 1 |
2 other studies available for mesalamine and Lymphocytosis
Article | Year |
---|---|
Collagenous and lymphocytic colitis. evaluation of clinical and histological features, response to treatment, and long-term follow-up.
Topics: Aged; Budesonide; Cholestyramine Resin; Colitis; Collagen; Colon; Female; Follow-Up Studies; Humans; | 2003 |
T-large granular lymphocyte leukemia accompanied by an increase of natural killer cells (CD3-) and associated with ulcerative colitis and autoimmune hepatitis.
Topics: Anti-Inflammatory Agents; Colitis, Ulcerative; Gene Rearrangement; Genes, T-Cell Receptor beta; Hepa | 2001 |